CD8A and colorectal carcinoma: Notably, in MSI-H CRC, a higher Ttex/CD8+ ratio has been associated with improved relapse-free survival, suggesting that the presence of Ttex reflects a sustained immune response rather than immune failure (4, 6, 8).